Masatoshi Ban

Title: A Profile of Inventor Masatoshi Ban and His Contributions to Pharmaceutical Innovations

Introduction: Masatoshi Ban is a noteworthy inventor based in Gifu, Japan, known for his significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Ban’s work centers around innovative chemical compounds that have the potential to enhance therapeutic applications.

Latest Patents: One of Ban's latest patents includes novel eburnamonine oxime derivatives, along with their salts and pharmaceutical agents. The patent discloses a variety of eburnamonine oxime compounds, described using specific chemical formulas that indicate the characteristics of the derivatives. These compounds include variable groups such as hydrogen, alkyl, or aryl groups, which offer significant functionality for medicinal applications. Additionally, another patent presents 2,5-benzodiazocine derivatives and their salts, featuring a central structure that can include various modifications to enhance CNS activity. These derivatives are integral in the development of pharmaceutical agents that target the central nervous system.

Career Highlights: Throughout his career, Masatoshi Ban has been associated with reputable organizations, such as Sanwa Kagaku Kenkyusho Co., Ltd. His work at this company has contributed significantly to advancements in pharmaceutical research and the development of new chemical entities.

Collaborations: During his professional journey, Ban has collaborated with prominent coworkers in the field, including Yutaka Baba and Takayuki Shioiri. Their teamwork has facilitated the exchange of ideas and fostered innovations within pharmaceutical science.

Conclusion: Masatoshi Ban stands out as a prominent figure in the realm of pharmaceutical inventions, with a focus on novel compounds and their therapeutic potential. His array of patents showcases his dedication to advancing medicine through innovative research, making him a valuable asset to the scientific community.